Company Description

PebRx s a preclinical-stage biotechnology company developing therapeutics and diagnostics targeting inflammation of the brain. Its pipeline focuses on novel, brain-penetrant therapeutics addressing neurovascular inflammation arising from dysfunctional lipid trafficking and metabolism.